Uniquely, this is a second recurrent (2R) astrocytoma patient sample with IDH1(R132H) mutation, reported as a prominent case study in the newly developed scOne-seq technology (see the original study for more details about the sample)18. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).